| [1] |
Yuen MF, Hou JL, Chutaputti A. Hepatocellular carcinoma in the Asia pacific region[J]. J Gastroenterol Hepatol,2009, 24(3): 34 6-53.
|
| [2] |
Amarapurkar D, Han KH, Chan HL, et al.Application of surveillance programs for hepatocellular carcinoma in the Asia- Pacifi c Region[J]. J Gastroenterol Hepatol, 2009, 24(6): 955-61.
|
| [3] |
Mendizabal M, Reddy KR. Current management of hepatocellular carcinoma[J]. Med Clin North Am,2009, 93(4): 885-900.
|
| [4] |
Jepsen K, Gleiberman AS, Shi C, et al. Cooperative regulation in development by SMRT and FOXP1[J]. Genes Dev,2008, 22(6): 74 0-5.
|
| [5] |
Myatt SS, Lam EW. The emerging roles of Forkhead box (Fox) proteins in cancer[J]. Nat Rev Cancer, 2007, 7(11): 847-59.
|
| [6] |
Bates GJ, Fox SB, Han C, et al. Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas[J]. Breast Cancer Res Tteat, 2008, 111(3): 453-9.
|
| [7] |
Rayoo M, Yan M, Takano EA, et al. Expression of the forkhead box transcription factor FOXPl is associated with oestrogen receptor alpha, ocstrogen receptor beta and improved survival in familial breast cancer[J]. J Clin Pathol, 2009, 62(10): 896-902.
|
| [8] |
Takayama K, Horie-Inoue, Ikeda K, et al. FOXP1 is an androgenresponsive transcription factor that negatively regufates androgen receptor signaling in prostate cancer cells[J]. Biochem Biophys Res Commun, 2008, 374(2): 388-93.
|
| [9] |
Toma MI, Weber T, Meinhardt M, et al. Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinoma[J]. Cancer Invest, 2011, 29(2): 123-9.
|
| [10] |
Chen L, Qin J, Zhu YY. The progress of RNA interference research in the fi eld of medcine[J]. Yao Wu Sheng Wu Ji Shu, 2009, 16(1): 83 -9. [陈莉,秦婧,朱远源.在医药领域中RNA干扰研究进展[J]. 药物生物技术, 2009, 16(1): 83-9.]
|
| [11] |
Ding ZY, Liang HJ. Advance in RNAi mediated with lentivirusbased vectors[J].Yi Xue Yan Jiu Za Zhi, 2009, 38(4): 15-6. [丁震 宇，梁后杰. 慢病毒载体介导RNAi的研究进展[J]. 医学研究杂 志, 2009, 38(4): 15-6.]
|
| [12] |
Morris KV, Rossi JJ. Lentiviral-mediated delivery of siRNAs for antiviral therapy[J]. Gene Ther, 2006, 13(6): 553-8.
|
| [13] |
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) ) Method[J]. Methods, 2001, 25(4): 402-8.
|
| [14] |
Pariani MJ, Spencer A, Graham JM, et al. A 785kb deletion of 3p 14.1p13, including the FOXPl gene, associated with speech delay, contractures, hypertonia and blepharophimosis[J]. Eur J Med Genet, 2009, 52(2-3): 123-7.
|
| [15] |
Taylor BS, Schultz N, Hieronymus H, et al. Integrative genomic profi ling of human prostate cancer[J]. Cancer Cell, 2010, 18(1): 11 -22.
|
| [16] |
Brown PJ, Ashe SL, Leich E, et al. Potentially oncogenie B-cell activation induced smaller isoforns of FOXP1 are highly expressed in the activated B cell like subtype of DLBCL[J]. Blood, 2008, 111(5): 2816-24.
|
| [17] |
Datta J, Kutay H, Nasser MW, et al. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis[J]. Cancer Res, 2008, 68(13): 5049-58.
|
下载:
